InMed Pharmaceuticals Inc (INM) stock news · rev $4.9M
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
This INM news page leads with what InMed Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for INM yet. We will not pad this page with generic market recap.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INM stock page; for the tape open the quote page.
INM stock news FAQ
What are INM's latest revenue and net income?
Latest cached InMed Pharmaceuticals Inc (INM) revenue for Jun 30, 2025 was $4.9M. Net income was -$8.2M. Statements: https://lician.com/financials/inm
How did INM revenue change from the prior cached period?
Cached InMed Pharmaceuticals Inc (INM) revenue was up 7.5% from $4.6M (Jun 30, 2024) to $4.9M (Jun 30, 2025). Statements: https://lician.com/financials/inm
What is INM's market cap?
InMed Pharmaceuticals Inc (INM) market cap is $5.2M on the latest cached fundamentals snapshot.
What kind of company is INM?
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Where is INM stock news listed?
Cached stock news for InMed Pharmaceuticals Inc (INM) is listed at https://lician.com/news/inm. Filings: https://lician.com/sec/inm
Not investment advice.